Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-15 | Amended | $18,986,300 | Unknown | Debt Only | SEC link | |
| 2024-07-26 | New | $13,986,300 | $13,986,300 | Debt Only | 06b | SEC link |
| 2022-06-29 | Amended | $3,500,000 | $1,360,000 | Debt Only | 06b | SEC link |
| 2022-06-03 | New | $2,140,000 | $2,140,000 | Debt Only | 06b | SEC link |
| 2018-11-28 | New | $2,927,147 | $2,927,147 | Equity Only | 06b | SEC link |
| 2015-10-01 | Amended | $534,999 | $409,999 | Equity Only | 06b | SEC link |
| 2015-01-06 | New | $125,000 | $125,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Sam Bartholomew | Director |
| Joseph C. Cook Iii | Director |
| Tobin Dickerson | Director, Executive |
| Deborah Johnson | Director |
| George Mahaffey | Director, Executive |
| Tahir Mahmood | Director, Executive |
| Philippe ` Nore | Director, Executive |
| Andrew Offer | Director |
| Deborah Rice Johnson | Director |
| Patrick Rivelli | Director |
| Ron Rocca | Director, Executive |
| Tyler Whitmore | Director |